stockcue

RXRX (Recursion Pharmaceuticals, Inc.): risk score 49/100 — Hold · Valuation 24/100 · Financial health 73/100 · Growth 49/100 · price $3.72. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s